A Long Term Effects of a New Onset Psychosis after DBS Treated with Quetiapine in a Patient with Parkinson's Disease
Deep Brain Stimulation represents a therapeutic option for PD patients. In this paper, we present and discuss a case of acute delirium and psychosis manifesting after DBS in a 58-years-old man affected by Parkinson's Disease. We highlight the importance of an exhaustive psychiatric evaluation i...
Main Authors: | , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Korean Neuropsychiatric Association
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310913/ |
id |
pubmed-4310913 |
---|---|
recordtype |
oai_dc |
spelling |
pubmed-43109132015-02-10 A Long Term Effects of a New Onset Psychosis after DBS Treated with Quetiapine in a Patient with Parkinson's Disease Piccoli, Sara Perini, Giulia Pizzighello, Silvia Vestri, Alec Ferri, Giovanni Toffanin, Tommaso Follador, Halima Martinuzzi, Andrea Case Report Deep Brain Stimulation represents a therapeutic option for PD patients. In this paper, we present and discuss a case of acute delirium and psychosis manifesting after DBS in a 58-years-old man affected by Parkinson's Disease. We highlight the importance of an exhaustive psychiatric evaluation in candidates for DBS and we underline the severity and non-reversibility of some adverse events associated with the implantation, suggesting the use of Quetiapine in the management of these effects. Acute psychosis may be listed as a potential severe adverse event associated with DBS, even in patients without a clear cut previous history of psychiatric disorders. Korean Neuropsychiatric Association 2015-01 2015-01-12 /pmc/articles/PMC4310913/ /pubmed/25670958 http://dx.doi.org/10.4306/pi.2015.12.1.146 Text en Copyright © 2015 Korean Neuropsychiatric Association http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
repository_type |
Open Access Journal |
institution_category |
Foreign Institution |
institution |
US National Center for Biotechnology Information |
building |
NCBI PubMed |
collection |
Online Access |
language |
English |
format |
Online |
author |
Piccoli, Sara Perini, Giulia Pizzighello, Silvia Vestri, Alec Ferri, Giovanni Toffanin, Tommaso Follador, Halima Martinuzzi, Andrea |
spellingShingle |
Piccoli, Sara Perini, Giulia Pizzighello, Silvia Vestri, Alec Ferri, Giovanni Toffanin, Tommaso Follador, Halima Martinuzzi, Andrea A Long Term Effects of a New Onset Psychosis after DBS Treated with Quetiapine in a Patient with Parkinson's Disease |
author_facet |
Piccoli, Sara Perini, Giulia Pizzighello, Silvia Vestri, Alec Ferri, Giovanni Toffanin, Tommaso Follador, Halima Martinuzzi, Andrea |
author_sort |
Piccoli, Sara |
title |
A Long Term Effects of a New Onset Psychosis after DBS Treated with Quetiapine in a Patient with Parkinson's Disease |
title_short |
A Long Term Effects of a New Onset Psychosis after DBS Treated with Quetiapine in a Patient with Parkinson's Disease |
title_full |
A Long Term Effects of a New Onset Psychosis after DBS Treated with Quetiapine in a Patient with Parkinson's Disease |
title_fullStr |
A Long Term Effects of a New Onset Psychosis after DBS Treated with Quetiapine in a Patient with Parkinson's Disease |
title_full_unstemmed |
A Long Term Effects of a New Onset Psychosis after DBS Treated with Quetiapine in a Patient with Parkinson's Disease |
title_sort |
long term effects of a new onset psychosis after dbs treated with quetiapine in a patient with parkinson's disease |
description |
Deep Brain Stimulation represents a therapeutic option for PD patients. In this paper, we present and discuss a case of acute delirium and psychosis manifesting after DBS in a 58-years-old man affected by Parkinson's Disease. We highlight the importance of an exhaustive psychiatric evaluation in candidates for DBS and we underline the severity and non-reversibility of some adverse events associated with the implantation, suggesting the use of Quetiapine in the management of these effects. Acute psychosis may be listed as a potential severe adverse event associated with DBS, even in patients without a clear cut previous history of psychiatric disorders. |
publisher |
Korean Neuropsychiatric Association |
publishDate |
2015 |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310913/ |
_version_ |
1613182232201003008 |